Unknown

Dataset Information

0

Prestimulation of CD2 confers resistance to HIV-1 latent infection in blood resting CD4 T cells.

ABSTRACT: HIV-1 infects blood CD4 T cells through the use of CD4 and CXCR4 or CCR5 receptors, which can be targeted through blocking viral binding to CD4/CXCR4/CCR5 or virus-cell fusion. Here we describe a novel mechanism by which HIV-1 nuclear entry can also be blocked through targeting a non-entry receptor, CD2. Cluster of differentiation 2 (CD2) is an adhesion molecule highly expressed on human blood CD4, particularly, memory CD4 T cells. We found that CD2 ligation with its cell-free ligand LFA-3 or anti-CD2 antibodies rendered blood resting CD4 T cells highly resistant to HIV-1 infection. We further demonstrate that mechanistically, CD2 binding initiates competitive signaling leading to cofilin activation and localized actin polymerization around CD2, which spatially inhibits HIV-1-initiated local actin polymerization needed for viral nuclear migration. Our study identifies CD2 as a novel target to block HIV-1 infection of blood resting T cells.

SUBMITTER: He S 

PROVIDER: S-EPMC8571718 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Prestimulation of CD2 confers resistance to HIV-1 latent infection in blood resting CD4 T cells.

He Sijia S   Guo Jia J   Fu Yajing Y   Spear Mark M   Qin Chaolong C   Fu Shuai S   Cui Zongqiang Z   Jin Wenwen W   Xu Xuehua X   Chen Wanjun W   Shang Hong H   Wu Yuntao Y  

iScience 20211016 11

HIV-1 infects blood CD4 T cells through the use of CD4 and CXCR4 or CCR5 receptors, which can be targeted through blocking viral binding to CD4/CXCR4/CCR5 or virus-cell fusion. Here we describe a novel mechanism by which HIV-1 nuclear entry can also be blocked through targeting a non-entry receptor, CD2. Cluster of differentiation 2 (CD2) is an adhesion molecule highly expressed on human blood CD4, particularly, memory CD4 T cells. We found that CD2 ligation with its cell-free ligand LFA-3 or an  ...[more]

Similar Datasets

Unknown The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells.
| S-EPMC2760144 | biostudies-other
Unknown SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.
| S-EPMC3828732 | biostudies-literature
Unknown Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection.
| S-EPMC3386138 | biostudies-other
Unknown IP-10 Promotes Latent HIV Infection in Resting Memory CD4<sup>+</sup> T Cells <i>via</i> LIMK-Cofilin Pathway.
| S-EPMC8383741 | biostudies-literature
Unknown High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.
| S-EPMC3754042 | biostudies-literature
Unknown CCR5 Gene Editing of Resting CD4(+) T Cells by Transient ZFN Expression From HIV Envelope Pseudotyped Nonintegrating Lentivirus Confers HIV-1 Resistance in Humanized Mice.
| S-EPMC4222653 | biostudies-literature
Unknown Exosomal Tat protein activates latent HIV-1 in primary, resting CD4+ T lymphocytes.
| S-EPMC5928859 | biostudies-literature
Unknown Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individuals.
| S-EPMC7728277 | biostudies-literature
Unknown Initial productive and latent HIV infections originate in vivo by infection of resting T cells.
| S-EPMC10645380 | biostudies-literature
Unknown A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
| S-EPMC377486 | biostudies-literature